Joel Isaacson & Co’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7K Hold
12,000
﹤0.01% 480
2026
Q1
$25.6K Hold
12,000
﹤0.01% 452
2025
Q4
$18.4K Hold
12,000
﹤0.01% 460
2025
Q3
$17.6K Hold
12,000
﹤0.01% 446
2025
Q2
$21.4K Hold
12,000
﹤0.01% 418
2025
Q1
$17.5K Sell
12,000
-10,000
-45% -$19.5K ﹤0.01% 398
2024
Q4
$33.7K Sell
22,000
-30,000
-58% -$48.8K ﹤0.01% 377
2024
Q3
$94.1K Buy
52,000
+30,000
+136% +$54.8K ﹤0.01% 362
2024
Q2
$37K Hold
22,000
﹤0.01% 346
2024
Q1
$56.8K Hold
22,000
﹤0.01% 329
2023
Q4
$43.6K Hold
22,000
﹤0.01% 307
2023
Q3
$20.5K Hold
22,000
﹤0.01% 305
2023
Q2
$25.1K Hold
22,000
﹤0.01% 320
2023
Q1
$15.4K Hold
22,000
﹤0.01% 324
2022
Q4
$15.7K Buy
+22,000
New +$19.2K ﹤0.01% 320

Other funds holding CGEN

Joel Isaacson & Co's CGEN Position: Q2 2026 in Review

Joel Isaacson & Co held its Compugen (CGEN) position steady in Q2 2026 at 12,000 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #480.

Joel Isaacson & Co first reported a position in CGEN in Q4 2022 and has held it in 15 quarters since. The position peaked at $94.1K in Q3 2024. 29 funds tracked by Wall St. Rank hold CGEN as of Q2 2026.

  • Joel Isaacson & Co held 12,000 shares of Compugen worth $25.7K as of Q2 2026.
  • Joel Isaacson & Co left its Compugen share count unchanged in Q2 2026.
  • Compugen made up ﹤0.01% of Joel Isaacson & Co's portfolio in Q2 2026, its #480 holding.
  • Joel Isaacson & Co first reported a position in Compugen in Q4 2022 and has held it in 15 quarters since.
  • Joel Isaacson & Co's Compugen position peaked at $94.1K in Q3 2024.
  • 29 funds tracked by Wall St. Rank held Compugen as of Q2 2026.

Based on Joel Isaacson & Co's 13F filing for Q2 2026, filed 4 Aug 2026.